医药和生物技术领域的合作开发协议（2016-2026）

建立更强大的合作伙伴关係—探索全球生物製药产业的合作开发模式、合约条款和承包商趋势

"医药和生物技术领域的合作开发协议（2016-2026）" 报告对生命科学领域的合作开发协议进行了最全面的分析。本报告涵盖近十年的活动，提供丰富的数据洞察，深入分析企业如何共同开发候选药物、分担开发风险以及协调商业化责任。

本次全面修订版分析了实际的合作开发协议，包括财务条款、合作策略，以及（如有）向美国证券交易委员会 (SEC) 提交的合约文件的连结。

免费报告样本

主要特点和优势

• 涵盖 2016 年至 2026 年的合约

追踪合作开发协议的演变并识别策略模式。

• 合约结构与条款分析

了解合作开发协议的架构－每家公司的贡献、风险分担方式、利润分配方式。

• 自信地比较财务指标

查看关键金额、里程碑付款、股权比例等，以帮助您建立自己的合约模型。

• 取得实际合约文本

如果可以，请查阅实际提交的合同，以深入了解合同条款、定义和触发条件。

• 辨识最活跃的参与者

识别签署联合开发协议的前 25 家公司，并了解它们不同的方法。

目录 - 章节架构

第一章：引言

概述共同开发协议、公司选择此模式的原因以及本报告的结构。

第二章：共同开发活动的趋势

依年份、产业、治疗领域和地区对联合开发协议进行视觉化和描述性分析。

第三章：合约结构与关键条款

分析公司如何分享智慧财产权、开发责任、成本和商业化权利。

第四章：高价值联合开发协议

依揭露金额顺序介绍关键协议。包括财务条款、策略依据以及公开的原始协议连结。

第五章：25 家活跃的合作开发协议公司

公司简介，包括每家公司的合约历史和合作模式。也提供每家公司完整合约记录的连结。

第六章：综合合约目录

合作开发协议详细索引（依以下方式组织）：

• 公司名称（依字母顺序排列）
• 治疗领域
• 技术类型
• 合约类型
• 每笔记录都连结到“目前合约资料库”，其中也提供合约文件。
• 本报告的目标读者是谁？
• 业务拓展和授权专业人士 - 评估成功交易的结构、条款和合作伙伴角色。
• 主管与投资人 - 了解合作开发如何协助加速产品研发进程并降低资本消耗。
• 法律和合约经理 - 参考实际合约条款和交易机制，帮助您起草自己的条款和条件。
• 商业和策略规划人员 - 了解合作开发伙伴之间如何分配权利、责任和利益。
• 本报告的重要性
• 随着研发成本的上升和研发週期的缩短，合作开发协议提供了一种极具吸引力的解决方案，能够实现风险共担、激励机制的协调以及快速执行。本报告将帮助您了解市场标准条款、可协商要素以及领先企业在合作研发伙伴关係中取得成功的策略。
• 从真实的合约案例中学习，掌握产业领导者的合作方法，并建立更牢固的伙伴关係。立即订购 "2016-2026 年医药与生技合作开发协议" 。

目录

摘要整理

第一章：引言

第二章：联合开发交易趋势

• 引言
• 联合开发协议的定义
• 2016年以来联合开发协议的趋势
  • 联合开发交易年度趋势（2016-2026）
  • 依开发阶段划分的共同开发交易（2016-2026）
  • 依产业划分的共同开发交易（2016-2026）
  • 依治疗领域划分的共同开发交易（2016-2026）
  • 依技术类型划分的共同开发交易（2016-2026）
  • 依最活跃公司划分的共同开发交易（2016-2026）
• 签订联合开发伙伴关係协议的原因
• 联合开发协议的未来

第三章 合作开发协议结构概述

• 引言
• 合作开发协议的结构

第四章 - 领先的合作开发协议

• 引言
• 以价值排名的顶级合作开发交易

第五章 - 最活跃的25位合作开发交易撮合者

• 引言
• 最活跃的25位合作开发交易撮合者

第六章 - 包含交易的合作开发协议目录

• 简介
• 2016年至2026年依交易类型划分的合作开发协议
• 交易目录
• 依公司划分的合作开发交易目录 (AZ)
• 依治疗领域划分的合作开发交易目录
• 以技术类型划分的共同开发交易目录
• 关于研究公司
• 当前合作伙伴关係
• 当前协议
• 近期合作报告标题

Power Smarter Partnerships: Explore Co-development Models, Terms, and Dealmakers Across the Global Biopharma Landscape

The Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 report delivers the most comprehensive analysis of collaborative development agreements in the life sciences sector. Spanning nearly a decade of activity, the report provides a data-rich view into how companies co-develop drug candidates, share development risk, and align commercialization responsibilities.

This fully updated edition explores real-world co-development deals and includes financial terms, partnering strategies, and links to actual SEC-filed contract documents where available.

Free report sample

Key Features & Benefits

• Covers Deals from 2016 to 2026

Track the evolution of co-development dealmaking and identify strategic patterns.

• Analyze Deal Structures and Terms

Understand how co-development deals are structured-who contributes what, how risks are shared, and how profits are split.

• Benchmark Financials with Confidence

Review headline values, milestone payments, and equity contributions to support your own deal modeling.

• Access Real Contract Language

Where available, examine actual contract filings to gain insight into deal clauses, definitions, and triggers.

• Spot the Most Active Players

Identify the top 25 companies engaging in co-development deals-and learn what differentiates their approach.

What's Inside - Chapter Breakdown

Chapter 1: Introduction

An overview of co-development dealmaking, why companies choose this model, and how this report is structured.

Chapter 2: Trends in Co-development Activity

Visual and narrative analysis of co-development deals by year, sector, therapeutic area, and region.

Chapter 3: Deal Structures & Key Clauses

Breaks down how companies share IP, development responsibilities, costs, and commercialization rights.

Chapter 4: High-Value Co-development Deals

Profiles of major deals sorted by disclosed value. Includes financial terms, strategic rationale, and links to original contracts where publicly available.

Chapter 5: Top 25 Active Co-development Dealmakers

Company profiles with deal histories and partnership approaches-including links to each company's full deal records.

Chapter 6: Comprehensive Deal Directory

Detailed index of co-development deals organized by:

• Company A-Z
• Therapy area
• Technology type
• Deal type
• Each record links to the Current Agreements database, with contract documents where available.
• Who Should Use This Report?
• Business Development & Licensing Professionals - Evaluate structures, terms, and partner roles across successful deals.
• C-Level Executives & Investors - Understand how collaborative development can accelerate product pipelines and reduce burn.
• Legal & Contract Managers - Benchmark real-world clauses and deal mechanics to guide your own term sheets.
• Commercial & Strategic Planners - Learn how rights, responsibilities, and revenues are allocated across co-development partners.
• Why This Report Matters
• As development costs rise and timelines tighten, co-development deals offer a compelling solution-shared risk, aligned incentives, and faster execution. This report helps you understand what's market standard, what's negotiable, and what leading companies are doing to succeed in shared R&D partnerships.
• Learn from real deals. See how the leaders collaborate. Build stronger partnerships. Order your copy of Co-development Deals in Pharmaceuticals and Biotechnology 2016-2026 today.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in co-development dealmaking

• 2.1. Introduction
• 2.2. Definition of co-development deal
• 2.3. Trends in co-development deals since 2016
  • 2.3.1. Co-development dealmaking by year, 2016-2026
  • 2.3.2. Co-development dealmaking by phase of development, 2016-2026
  • 2.3.3. Co-development dealmaking by industry sector, 2016-2026
  • 2.3.4. Co-development dealmaking by therapy area, 2016-2026
  • 2.3.5. Co-development dealmaking by technology type, 2016-2026
  • 2.3.6. Co-development dealmaking by most active company, 2016-2026
• 2.4. Reasons for entering into co-development partnering deals
• 2.5. The future of co-development deals

Chapter 3 - Overview of co-development deal structure

• 3.1. Introduction
• 3.2. Co-development agreement structure

Chapter 4 - Leading co-development deals

• 4.1. Introduction
• 4.2. Top co-development deals by value

Chapter 5 - Top 25 most active co-development dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active co-development dealmakers

Chapter 6 - Co-development deals including contracts directory

• 6.1. Introduction
• 6.2. Co-development deals with contracts 2016-2026
• Deal directory
• Deal directory - co-development dealmaking by companies A-Z
• Deal directory - co-development dealmaking by therapy area
• Deal directory - co-development dealmaking by technology type
• About Biopharma Research Ltd
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of co-development deal
• Figure 2: Trends in co-development deal announcements, 2016-2026
• Figure 3: Co-development deals signed at each phase of development, 2016-2026
• Figure 4: Co-development deals by industry sector, 2016-2026
• Figure 5: Co-development deals by therapy area, 2016-2026
• Figure 6: Co-development deals by technology type, 2016-2026
• Figure 7: Top 25 most active co-development dealmakers, 2016-2026
• Figure 8: Top co-development deals by value, 2016-2026
• Figure 9: Most active co-development dealmakers, 2016-2026